Baseline C-reactive protein (CRP) and plasma anti-TNF concentration in patients with active Crohn's disease treated with certolizumab pegol: P-30.


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles